BlackRock (KRMD) files amendment reporting 2.29M shares, 4.9% stake

Rhea-AI Filing Summary

BlackRock, Inc. filed an amendment to a Schedule 13G reporting beneficial ownership of 2,292,477 shares of Koru Medical Systems Inc. The filing states BlackRock has 2,256,191 shares of sole voting power, represents 4.9% of the class, and is signed by a Managing Director.

Insights

Institutional Ownership Analyst

BlackRock reports a sub-5% passive stake in Koru Medical Systems.

BlackRock's Schedule 13G amendment lists 2,292,477 shares beneficially owned, with 2,256,191 shares showing sole voting power. The filing characterizes the position as passive ownership under beneficial-ownership rules.

Ownership at 4.9% is below the 5% threshold that often triggers additional reporting or voting-control scrutiny; subsequent filings will show if the stake changes.

Key Figures

Beneficially owned shares: 2,292,477 shares Sole voting power: 2,256,191 shares Percent of class: 4.9% +2 more

5 metrics

Beneficially owned shares 2,292,477 shares Amount beneficially owned reported on Schedule 13G/A

Sole voting power 2,256,191 shares Shares with sole power to vote or direct the vote

Percent of class 4.9% Percent of common stock class beneficially owned

CUSIP 759910102 CUSIP for Koru Medical Systems common stock

Filing signature date 04/27/2026 Signature date on the amended Schedule 13G/A

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment to Schedule 13G reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 2292477"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 2292477"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

KORU MEDICAL SYSTEMS INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

759910102

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 759910102

1

Names of Reporting Persons

BlackRock, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,256,191.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,292,477.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,292,477.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KORU MEDICAL SYSTEMS INC
(b)	Address of issuer's principal executive offices: 100 Corporate Drive Mahwah NJ 07430
Item 2.
(a)	Name of person filing: BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)	Address or principal business office or, if none, residence: BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)	Citizenship: See Item 4 of Cover Page
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 759910102
Item 4.	Ownership
(a)	Amount beneficially owned: 2292477
(b)	Percent of class: 4.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2256191
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2292477
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of KORU MEDICAL SYSTEMS INC. No one person's interest in the common stock of KORU MEDICAL SYSTEMS INC is more than five percent of the total outstanding common shares.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BlackRock, Inc.

Signature:	Spencer Fleming
Name/Title:	Managing Director
Date:	04/27/2026

Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

FAQ

What does BlackRock's Schedule 13G/A for KRMD report?

It reports that BlackRock beneficially owns 2,292,477 shares of Koru Medical Systems, representing 4.9% of the class. The filing lists 2,256,191 shares as sole voting power and is signed by a Managing Director on 04/27/2026.

Does BlackRock control Koru Medical Systems after this filing (KRMD)?

No; the filing shows a passive ownership filing at 4.9%, below common control thresholds. BlackRock reports sole voting power for 2,256,191 shares, but the Schedule 13G classification indicates passive, not active, control intentions.

How much voting power does BlackRock report for KRMD?

BlackRock reports 2,256,191 shares as sole power to vote or direct the vote for Koru Medical Systems common stock. The filing also shows zero shared voting power and sole dispositive power over 2,292,477 shares.

Why is this filing an amendment (Schedule 13G/A) for KRMD?

An amended Schedule 13G/A updates earlier beneficial ownership details; this amendment restates beneficial ownership at 2,292,477 shares and voting powers. Amendments are routine when holdings or disclosures change for reporting persons like BlackRock.

Will BlackRock need to file a different form if its stake rises above 5% in KRMD?

Yes; if BlackRock's ownership surpasses the 5% threshold or shifts from passive to active, reporting obligations typically change and filings such as a Schedule 13D or additional amendments would be required under SEC rules.